C Michael Gibson Selected Research

Thrombosis (Thrombus)

3/2024	Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
2/2024	Thrombin as target for prevention of recurrent events after acute coronary syndromes.
1/2024	Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.
11/2023	Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.
2/2023	External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
1/2023	Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
1/2023	Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
1/2023	Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
1/2023	Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial.
11/2022	Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Michael Gibson Research Topics

Disease

230	Myocardial Infarction 05/2024 - 01/2002
151	Hemorrhage 03/2024 - 02/2002
134	ST Elevation Myocardial Infarction 11/2023 - 03/2002
109	Thrombosis (Thrombus) 03/2024 - 07/2002
105	Acute Coronary Syndrome 02/2024 - 04/2002
53	Infarction (Infarctions) 01/2023 - 01/2002
45	Ischemia 03/2022 - 02/2002
35	Stroke (Strokes) 04/2024 - 09/2005
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2002
29	Heart Failure 01/2023 - 03/2002
27	Atrial Fibrillation 01/2023 - 05/2005
23	Unstable Angina 05/2017 - 02/2002
21	Venous Thromboembolism 04/2024 - 03/2014
16	Non-ST Elevated Myocardial Infarction 11/2020 - 11/2002
12	Pulmonary Embolism 04/2024 - 05/2005
12	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 11/2002
12	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 04/2003
11	Pathologic Constriction (Stenosis) 01/2016 - 02/2002
9	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 01/2015
9	Inflammation (Inflammations) 06/2022 - 02/2003
9	Death (Near-Death Experience) 11/2020 - 11/2013
8	Atherosclerosis 01/2023 - 02/2003
8	COVID-19 01/2023 - 01/2020
8	Diabetes Mellitus 01/2020 - 10/2002
7	Hypertension (High Blood Pressure) 01/2023 - 02/2003
6	Stable Angina 11/2018 - 08/2004
5	Necrosis 06/2022 - 05/2005
5	Renal Insufficiency (Renal Failure) 01/2020 - 02/2003
5	Chest Pain (Chest Pains) 01/2020 - 05/2002
4	Peripheral Arterial Disease 03/2024 - 08/2004
4	Ischemic Stroke 01/2023 - 01/2017
4	Atherosclerotic Plaque (Atheroma) 01/2023 - 01/2021
4	Rupture 01/2022 - 06/2003
4	Infections 12/2021 - 10/2005
4	Chronic Renal Insufficiency 12/2021 - 06/2014

Drug/Important Bio-Agent (IBA)

58	Clopidogrel (Plavix)FDA Link 01/2022 - 08/2004
42	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024 - 12/2002
36	Glycoproteins (Glycoprotein)IBA 01/2023 - 11/2002
30	cangrelorIBA 03/2022 - 12/2009
29	RivaroxabanIBA 02/2024 - 05/2011
29	Enoxaparin (Lovenox)FDA LinkGeneric 02/2023 - 04/2002
28	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2024 - 07/2013
27	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
23	N(2)-(3-trifluoromethylphenyl)guanineIBA 06/2022 - 01/2002
22	AnticoagulantsIBA 01/2024 - 03/2005
21	Abciximab (ReoPro)FDA Link 10/2016 - 07/2003
21	Eptifibatide (Integrilin)FDA Link 04/2014 - 04/2003
20	omega-Chloroacetophenone (Mace)IBA 01/2023 - 02/2009
19	TicagrelorIBA 03/2024 - 07/2013
19	Heparin (Liquaemin)FDA LinkGeneric 07/2020 - 12/2002
19	Tirofiban (Aggrastat)FDA Link 01/2012 - 07/2002
18	betrixabanIBA 02/2023 - 03/2014
18	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023 - 10/2002
16	Vitamin K FDA Link 01/2024 - 06/2012
16	bivalirudin (Angiomax)FDA Link 01/2017 - 05/2006
13	Tenecteplase FDA Link 01/2020 - 04/2003
12	CSL112IBA 05/2024 - 10/2016
12	Thrombin FDA Link 02/2024 - 06/2006
11	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 10/2016
11	fibrin fragment D (D-dimer)IBA 02/2023 - 01/2015
11	TroponinIBA 01/2020 - 07/2002
11	AntithrombinsIBA 01/2020 - 04/2002
10	CholesterolIBA 04/2024 - 04/2009
10	C-Reactive ProteinIBA 06/2022 - 04/2002
10	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2020 - 04/2002
9	Factor Xa InhibitorsIBA 01/2023 - 05/2011
9	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 04/2002
9	MB Form Creatine KinaseIBA 04/2016 - 01/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2005
8	Prasugrel Hydrochloride FDA Link 01/2019 - 10/2006
8	GadoliniumIBA 08/2014 - 01/2006
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 12/2009
7	CreatinineIBA 01/2019 - 11/2003
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 05/2003
7	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 05/2007
6	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2020
6	Warfarin (Coumadin)FDA LinkGeneric 11/2019 - 06/2012
6	Troponin IIBA 01/2016 - 04/2002
5	apixabanIBA 01/2024 - 06/2012
5	LipidsIBA 01/2022 - 04/2009
5	Purinergic P2Y Receptor AntagonistsIBA 08/2020 - 12/2009
5	Platelet Membrane GlycoproteinsIBA 01/2020 - 06/2004
5	Factor Xa (Coagulation Factor Xa)IBA 01/2019 - 01/2012
4	human APOA1 proteinIBA 05/2024 - 01/2019
4	Hemoglobins (Hemoglobin)IBA 01/2023 - 04/2005
4	Troponin T (Troponin T1)IBA 06/2022 - 07/2002
4	LDL CholesterolIBA 03/2022 - 12/2018

Therapy/Procedure

161	Percutaneous Coronary Intervention 03/2024 - 04/2002
157	Therapeutics 04/2024 - 02/2002
75	Stents 03/2024 - 01/2002
32	Thrombolytic Therapy 11/2012 - 10/2002
24	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 07/2002
12	Thrombectomy 04/2024 - 03/2011
12	Patient Readmission 11/2019 - 04/2004
11	Drug-Eluting Stents 01/2023 - 06/2003
6	Blood Transfusion (Blood Transfusions) 01/2018 - 06/2007
5	Catheters 12/2023 - 07/2002
5	Length of Stay 12/2023 - 06/2002
5	Secondary Prevention 11/2023 - 03/2007
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2007